{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Tivic Health Systems, Inc.
Is Tivic Health Systems, Inc. overvalued or undervalued?
As of November 14, 2024, Tivic Health Systems, Inc. is considered overvalued with deteriorating investment appeal, reflected in its negative financial metrics and poor performance compared to peers.
Is Tivic Health Systems, Inc. technically bullish or bearish?
As of June 17, 2025, Tivic Health Systems, Inc. has a mildly bearish trend due to daily moving averages indicating bearish momentum, despite some mildly bullish signals from weekly indicators and a mixed monthly outlook.
What does Tivic Health Systems, Inc. do?
Tivic Health Systems, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, reporting net sales of $0 million and a net loss of $2 million as of March 2025, with a market cap of $3.67 million. Key metrics include a negative P/E ratio, a 0.00% dividend yield, and a return on equity of -186.96%.
How big is Tivic Health Systems, Inc.?
As of Jun 18, Tivic Health Systems, Inc. has a market capitalization of 3.67 million, with net sales of 0.52 million and a net profit of -5.68 million over the latest four quarters. Shareholder's funds are at 2.54 million and total assets at 2.81 million as of Dec 24.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
